Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
- DOI
- 10.1016/s0360-3016(00)01458-9
- Published
- 2001 Jan 1
- Container
- International journal of radiation oncology, biology, physics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0360-3016-00-01458-9,
title = {Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.},
author = {Prados MD and Wara WM and Sneed PK and McDermott M and Chang SM and Rabbitt J and Page M and Malec M and Davis RL and Gutin PH and Lamborn K and Wilson CB and Phillips TL and Larson DA},
year = {2001},
journal = {International journal of radiation oncology, biology, physics},
doi = {10.1016/s0360-3016(00)01458-9},
url = {https://doi.org/10.1016/s0360-3016(00)01458-9}
}RIS
TY - JOUR TI - Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. AU - Prados MD AU - Wara WM AU - Sneed PK AU - McDermott M AU - Chang SM AU - Rabbitt J AU - Page M AU - Malec M AU - Davis RL AU - Gutin PH AU - Lamborn K AU - Wilson CB AU - Phillips TL AU - Larson DA PY - 2001 JO - International journal of radiation oncology, biology, physics DO - 10.1016/s0360-3016(00)01458-9 UR - https://doi.org/10.1016/s0360-3016(00)01458-9 ER -
APA
MD, P., WM, W., PK, S., M, M., SM, C., J, R., M, P., M, M., RL, D., PH, G., K, L., CB, W., TL, P., & DA, L. (2001). Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.. International journal of radiation oncology, biology, physics. https://doi.org/10.1016/s0360-3016(00)01458-9
Source records
- pubmed · retrieved 2026-09-26T00:57:50.420Z